The field of cell and gene therapy (CGT) is experiencing an exciting transformation, marked by the recent FDA approval for the first CRISPR-based sickle cell treatment. As the CGT landscape rapidly expands, it’s important for stakeholders to address the challenges of scalability head-on. Cryopreservation emerges as a critical yet understated element in the scalability equation, essential for […]
View Blog
Part 5 of our Bridging the Gap Series (Summary of the webinar session held in April 2024) The April 5, 2024, the Bridging the Gap webinar brought together experts and patients in a dynamic discussion that highlighted the groundbreaking advancements and persistent challenges in the field of cell and gene therapy (CGT), particularly in cancer immunotherapy. Guest […]
View Blog
Part 4 of our Bridging the Gap Series (Summary of the webinar session held in March 2024) In the rapidly evolving landscape of cell and gene therapy, stakeholders from across the industry are coming together to envision the future of these groundbreaking treatments. Recently, a panel of experts engaged in a thought-provoking discussion as part of the Bridging […]
View Blog
Part 3 of our Bridging the Gap Series (Summary of the webinar session held in February 2024) Gene therapy has emerged as a promising frontier in modern medicine, offering revolutionary treatments for a range of diseases previously considered incurable. In a recent webinar as part of the Bridging the Gap series, guest speaker Dr. Bruce Levine, a cancer […]
View Blog
The ever-expanding horizon of medical research and healthcare delivery owes a significant debt to the technological advancements that have shaped the industry. Among the many innovations, cryopreservation stands out as a pivotal technique that preserves the integrity and functionality of biological specimens over extended periods. By freezing cells, tissues, and even whole organs at sub-zero […]
View Blog
Part 2 of our Bridging the Gap Series (Summary of the webinar session held in December 2023) As the cell therapy industry continues to expand, one organization is leading the way in advanced therapies, ensuring that hospital programs for cell treatments, such as CAR T-cell therapy, follow rigorous protocols and measure outcomes. This group, the Foundation for the […]
View Blog
Part 1 of our Bridging the Gap Series (Summary of the webinar session held in November 2023) Azenta and The Emily Whitehead Foundation have joined forces to launch an impactful new webinar series titled “Bridging the Gap.” The series aims to establish connections between scientific advancements, the biotechnology industry, and patient care, with the ultimate goal of […]
View Blog
Recap of an Interview with David Lewandowski, Azenta Life Sciences, and Carol Houts, Chief Strategy Officer at Germfree, in partnership with Phacilitate The cutting-edge domain of cell and gene therapies is undergoing a remarkable transformation, with innovative technologies and groundbreaking treatments promising to revolutionize healthcare. However, as these therapies continue to advance, so do the challenges surrounding […]
View Blog
Automation plays a vital role in the manufacturing process of advanced therapies, yet the cold chain infrastructure has often been overlooked. While automated solutions are sometimes perceived as expensive alternatives, recent studies have demonstrated the tangible benefits of automating cold chain processes, including time efficiencies and improved process rigor. This article explores a study conducted […]
View Blog
An Interview with Cryobiology Expert Dr. Jason Acker Freezing is stressful for mammalian cells – to say the least. Cells face potentially dangerous ice crystals and severe dehydration when cooled to very low temperatures. Yet, by carefully configuring a cryopreservation protocol, cells can be shielded from injury. Thanks to discoveries in cryobiology, scientists have preserved […]
View Blog